Genetic Testing for Risk
Genetic testing for an (also called "germline genetic testing") is a type of medical test that can help people learn about their risk for cancer. The test looks for changes in your that are linked to an increased risk for cancer.
How is genetic testing done?
Genetic testing can be done on blood, saliva or tissue. Once the sample is collected it is sent to a genetic testing lab. Tests usually take between 2-6 weeks for results.
Genetic testing can help people make medical decisions
Genetic testing can help people make medical decisions. Genetic test results can help people diagnosed with cancer make treatment decisions. Test results can help people learn about their future risk for cancer, and their options for lowering their risk or detecting cancer early.
More Information on Genetic Testing for Cancer Risk
Types of Genetic Tests
Genetic tests are not all the same. Learn about the different types of tests.
Benefits and Limitations
Genetic testing can provide important information, but there are limitations to testing.
Types of Test Results
It's important to understand the different types of test results and what they mean.
Genetic Testing Guidelines
Expert guidelines outline who is most likely to benefit from genetic testing.
Deciding about Testing
Following these steps can help you decide if genetic testing is right for you.
Genetic Counseling
Genetics experts can help you understand genetic testing and interpret test results.
Participate in Genetics Research
Below are some of our featured research studies looking at genetic testing. To search for additional studies, visit our Search and Enroll Tool.
More Resources
The following clinical trials include genetic counseling and testing.
- NCT02620852: WISDOM Study: Women Informed to Screen Depending on Measures of Risk offers women ages 40-74 the opportunity to undergo risk assessment and genetic testing in order to determine the best breast screening options based on their situation.
- NCT05562778: Chatbot to maximize genetic risk assessment. Researchers are testing whether a mobile health platform, known as a "chatbot" can improve rates of genetic testing among Medicaid patients with an elevated risk having an .
- NCT05427240: eHealth Delivery Alternative for Cancer Genetic Testing for (eReach2). This study will look at the effectiveness of offering web-based options for pre/post-test genetic counseling to provide equal or improved timely uptake of genetic services and testing.
- NCT05694559: Connecting Black Families in Houston, Texas to Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics. This study will provide genetic testing to 150 Black individuals and families and provide genetic counseling and risk reduction resources to individuals with a mutation linked to increased cancer risk.
Other genetic counseling or testing studies may be found here.